M
Marie Essig
Researcher at French Institute of Health and Medical Research
Publications - 151
Citations - 4243
Marie Essig is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Transplantation & Kidney disease. The author has an hindex of 30, co-authored 135 publications receiving 3474 citations. Previous affiliations of Marie Essig include Université Paris-Saclay & Versailles Saint-Quentin-en-Yvelines University.
Papers
More filters
Journal ArticleDOI
Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants.
Nassim Kamar,Nassim Kamar,Cyril Garrouste,Elizabeth B. Haagsma,Valérie Garrigue,Sven Pischke,Cecile Chauvet,Jérôme Dumortier,Amelie Cannesson,Elisabeth Cassuto-Viguier,Eric Thervet,Filomena Conti,Pascal Lebray,Harry R. Dalton,Robert N. Santella,Nada Kanaan,Marie Essig,Christiane Mousson,Sylvie Radenne,Anne Marie Roque-Afonso,Jacques Izopet,Jacques Izopet,Lionel Rostaing,Lionel Rostaing +23 more
TL;DR: A retrospective analysis of data from 17 centers from Europe and the United States that described the progression, outcomes, and factors associated with development of chronic HEV infection in recipients of transplanted solid organs found tacrolimus therapy is the main predictive factor for chronic hepatitis.
Journal ArticleDOI
Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations
Fadi Fakhouri,Lubka T. Roumenina,François Provôt,Marion Sallée,Sophie Caillard,Lionel Couzi,Marie Essig,David Ribes,Marie-Agnès Dragon-Durey,Franck Bridoux,Eric Rondeau,Véronique Frémeaux-Bacchi +11 more
TL;DR: A retrospective study to assess the presentation and outcomes of patients presenting with P-aHUS and the prevalence of alternative C3 convertase dysregulation and better understanding of complement dysregulation in pregnancy complications is essential.
Journal ArticleDOI
3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Increase Fibrinolytic Activity in Rat Aortic Endothelial Cells Role of Geranylgeranylation and Rho Proteins
Marie Essig,Geneviève Nguyen,Dominique Prié,Brigitte Escoubet,Jean-Daniel Sraer,Gérard Friedlander +5 more
TL;DR: HRI can modify the fibrinolytic potential of endothelial cells, likely via inhibition of geranylgeranylated Rho protein and disruption of the actin filaments.
Journal ArticleDOI
Drug-resistant cytomegalovirus in transplant recipients: a French cohort study
Sébastien Hantz,Françoise Garnier-Geoffroy,Marie-Christine Mazeron,Isabelle Garrigue,Pierre Merville,Catherine Mengelle,Lionel Rostaing,Franck Saint Marcoux,Marie Essig,Jean-Philippe Rerolle,Sébastien Cotin,Raphaëlle Germi,Sylvie Pillet,Yvon Lebranchu,Pascal Turlure,Sophie Alain +15 more
TL;DR: Findings for a French multicentre prospective cohort of 346 patients enrolled at initial diagnosis of CMV infection show the feasibility of surveying resistance, andVirological resistance was frequent in patients failing antiviral therapy.
Journal ArticleDOI
Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease
Marie Essig,Brigitte Escoubet,Dominique de Zuttere,Françoise Blanchet,Florence Arnoult,Emmanuel Dupuis,C. Michel,F. Mignon,Christine Clerici,François Vrtovsnik +9 more
TL;DR: This study shows that CV remodelling and ECF excess occurred at a very early stage of CKD, indicating that early therapeutic control of ECF may reduce CV events in CKD patients.